Clifford Chance has advised Scape Australia; MinterEllison has advised a syndicate of Mandated Lead Arrangers and Bookrunners; Allens has advised Brookfield. Scape Australia has completed the...
Scape Australia Acquires Aveo Group for A$3.85 Billion in Historic Real Estate Transaction
Keymed Biosciences’ Licensing Agreement With Ouro Medicines LLC
Clifford Chance advised Keymed Biosciences on the deal. Keymed Biosciences (HKSe: 02162) signed a licensing agreement granting Platina the exclusive worldwide rights to develop, manufacture and...
Keymed Biosiences’ Out-Licensing Transaction With Timberlyne Therapeutics Inc.
Clifford Chance advised Keymed Biosciences on the deal. Timberlyne Therapeutics, Inc. announced its US$180 million Series A financing to advance the development of CM313. Investors Abingworth,...
China Merchants Capital’s $870 Million Acquisition Of Fiber Link Global Limited
Clifford Chance advised China Merchants Capital on the deal. Slaughter and May advised Hong Kong Telecommunications (HKT) Limited. Hong Kong Telecommunications (HKT) Limited, an indirect wholly...
China Merchant Port Holdings (CMP)’s Acquisition Of 51% Stake in PT Nusantara Pelabuan Handal TBK
Clifford Chance has advised China Merchant Port Holdings (CMP) on the deal. China Merchant Port Holdings (CMP) has proposed the acquisition of a 51% controlling stake...